Invesaro

Stocks KBR Financial statements

Financial statements

KBR, INC. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data KBR, INC. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue4,2684,1714,9135,6395,7677,3396,5646,9567,7107,786
Cost of revenue4,1563,7324,3294,9865,1016,5335,7365,9796,6116,636
Gross profit1124395846536668068289771,0991,150
Selling, general and administrative244294341335393420487543578
General and administrative133244294
Operating income2826446836257231343449659778
Interest expense13216699728087115144158
Other non-operating income184-651-912-5-7-6
Pre-tax income33247396268-14146284-165508614
Income tax84-1938659281119295129156
Income from continuing operations-264374451
Net income to minority interests108297218246
Net income-61432281202-6327190-265375415
EBITDA73312531466172377480590815947
EPS, basic-0.372.631.721.23-0.440.191.36-1.962.793.21
EPS, diluted-0.372.631.721.22-0.440.191.26-1.962.793.21
Shares, basic (weighted)165163162163142140139135134129
Shares, diluted (weighted)165163163165142141156135134129
Dividend per share0.280.280.280.280.400.440.480.540.600.66

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents536439739712436370389304342500
Receivables5925109279388991,4119429811,0661,086
Other current assets10393108146121147164189173166
Total current assets2,0471,4251,9592,0111,6342,1521,7471,6511,8732,051
Property, plant and equipment145130121130130136182239237232
Lease right-of-use assets0175154158164138203217
Goodwill9599681,2651,2651,7612,0602,0872,1092,6302,677
Intangible assets248239516495683708645618763727
Long-term investments0
Other non-current assets127124147143135152294365396322
Total assets4,1443,6525,0525,3605,7056,2045,5665,5656,6636,584
Accounts payable5353505465725741,026637593772712
Accrued liabilities171186221209283317325340351342
Deferred revenue368463484356313275359328331
Short-term debt022271216364313649
Total current liabilities1,5591,0711,4191,5011,4551,8751,8211,5721,7821,688
Long-term debt4701,2261,1831,5841,8751,3761,8012,5332,547
Lease liabilities0192186188193176228236
Other non-current liabilities200171202124256219230290244279
Total liabilities3,3992,4553,3343,5074,0964,5213,9344,1715,1965,072
Total debt6504701,2481,2101,5961,8911,7401,8322,5692,596
Paid-in capital2,0882,0912,1902,2062,2222,2062,2352,5052,5262,552
Retained earnings4888541,2351,4371,3051,2871,4101,0721,3671,697
Treasury stock-769-818-817-817-864-943-1,143-1,279-1,494-1,818
Other comprehensive income-1,050-922-910-987-1,083-881-882-915-946-928
Shareholders' equity7571,2291,6981,8391,5801,6691,6201,3831,4531,503
Minority interests-12-8201429141211149
Total equity7251,1971,7181,8531,5821,6831,6321,3941,4671,512
Total liabilities and equity4,1443,6525,0525,3605,7056,2045,5665,5656,6636,584
Shares outstanding166162163164141140137135132126

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income-51440310209-4235192-261381403
Depreciation and amortization454863104115146137141156169
Stock-based compensation181210121212
Deferred income tax18-32327-14-38473713260
Change in receivables12192-203-16127-476455-325-2
Change in payables-6-19311223-40447-376-53147-70
Cash from operations61193165256367278396331462557
Capital expenditures-11-8-17-20-20-30-71-62-52-42
Acquisitions-911-4-3540-832-399-730-738-14
Purchases of investments0-7-61-39-5-10
Cash from investing-981-12-491-158-877-42837-70-77616
Stock issued002541255
Share buybacks-4-53-3-4-51-82-203-138-218-329
Dividends paid-46-45-44-46-54-61-66-72-79-84
Cash from financing584-290654-13322587-399-359374-403
Exchange rate effect-1112-2889-3-1513-1418
Net change in cash-347-97300-27-276-6619-8546155
Free cash flow50185148236347248325269410515
Interest paid12215280536366102124141
Income taxes paid491442154494947528283

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to July 3, 2026; growth uses fiscal years. Valuation uses the share price of $34.54 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin14.5%Gross profit / revenue.
Operating margin9.5%Operating income / revenue.
EBITDA margin11.7%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin7.5%Pre-tax income / revenue.
Net margin5.5%Net income / revenue.
FCF margin4.6%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin5.3%Cash from operations / revenue.
Effective tax rate26.1%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)25.9%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)6.4%Net income / average total assets.
Return on invested capital (ROIC)14.0%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue7.4%Selling, general and administrative expense / revenue.
Capex / revenue0.7%Capital expenditures / revenue.
D&A / revenue2.1%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y1.0%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y5.9%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y6.2%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y4.6%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y11.6%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y11.5%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y18.1%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y31.4%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y68.7%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y16.2%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y25.4%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y40.7%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y10.7%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y29.7%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS growth, 1y15.1%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y36.6%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y20.6%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y12.0%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y8.7%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y25.6%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y16.6%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y8.2%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y10.0%Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y11.2%Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y10.5%Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y3.4%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y-2.5%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y-1.0%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y-1.2%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y5.8%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y2.9%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-3.7%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-6.1%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-1.9%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.15xCurrent assets / current liabilities.
Quick ratio0.82x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.18x(Cash + short-term investments) / current liabilities.
Debt / equity1.56xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets38.3%Total debt / total assets.
Liabilities / assets75.4%Total liabilities / total assets.
Net debt$2.24BTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA2.49xNet debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage4.96xOperating income / interest expense.
Working capital$255.0MCurrent assets - current liabilities.
Goodwill and intangibles / assets50.4%(Goodwill + intangible assets) / total assets.
Tangible book value-$1.73BShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover1.16xRevenue / average total assets.
Fixed asset turnover34.0xRevenue / average property, plant and equipment.
Receivables turnover6.96xRevenue / average receivables.
Days sales outstanding52 days365 x average receivables / revenue.
Days payables41 days365 x average accounts payable / cost of revenue.
FCF conversion83.7%Free cash flow / net income, when net income is positive.
Capex / operating cash flow13.2%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$3.34Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$60.81Revenue / diluted weighted shares.
FCF per share$2.80Free cash flow / diluted weighted shares.
Operating cash flow per share$3.22Cash from operations / diluted weighted shares.
Book value per share$12.98Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share-$13.69Tangible book value / shares outstanding.
Cash per share$2.47(Cash + short-term investments) / shares outstanding.
Payout ratio20.0%Dividends paid / net income, when net income is positive.
Dividends / FCF23.9%Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF43.4%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$4.35BShare price x shares outstanding.
Enterprise value$6.59BMarket cap + total debt - cash - short-term investments.
P/E10.3xMarket cap / net income. Only when net income is positive.
P/S0.56xMarket cap / revenue.
P/B2.66xMarket cap / shareholders' equity. Only when equity is positive.
P/FCF12.3xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF10.6xMarket cap / cash from operations, when positive.
EV/Sales0.85xEnterprise value / revenue.
EV/EBIT8.98xEnterprise value / operating income, when both are positive.
EV/EBITDA7.33xEnterprise value / EBITDA, when both are positive.
EV/FCF18.6xEnterprise value / free cash flow, when both are positive.
FCF yield8.2%Free cash flow / market cap.
Earnings yield9.7%Net income / market cap (the inverse of P/E).
Dividend yield2.0%Dividends paid over the period / market cap.
Shareholder yield5.5%(Dividends paid + share buybacks) / market cap.
PEG0.28xP/E / EPS growth per year over 3 years (in percent). Only when both are positive.
What was KBR, INC.'s revenue in fiscal 2025?

KBR, INC. reported revenue of $7.79B for fiscal 2025, 1% higher than the year before.

Was KBR, INC. profitable in fiscal 2025?

Yes. Net income was $415.0M, a net margin of 5.3%.

How much free cash flow did KBR, INC. generate in fiscal 2025?

Cash from operations of $557.0M minus capital expenditures of $42.0M left free cash flow of $515.0M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to KBR, INC.